These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35775416)

  • 1. Fast challenge tests with gadolinium-based contrast agents to search for an alternative contrast media in allergic patients.
    Vega F; Lopez-Raigada A; Múgica MV; Blanco C
    Allergy; 2022 Oct; 77(10):3151-3153. PubMed ID: 35775416
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
    Heshmatzadeh Behzadi A; Prince MR
    Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset.
    Harr T; Jandus P
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):203-205. PubMed ID: 29939144
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
    Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
    Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of negative skin tests to gadolinium contrast agents.
    Chiriac AM; Audurier Y; Bousquet PJ; Demoly P
    Allergy; 2011 Nov; 66(11):1504-6. PubMed ID: 21854399
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
    Carr TF
    Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
    Thomsen HS
    Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
    Boehm I; Hungerbühler M; Heverhagen JT
    Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic reactions to gadolinium chelates.
    Runge VM
    AJR Am J Roentgenol; 2001 Oct; 177(4):944-5. PubMed ID: 11566710
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypersensitivity to gadolinium-based contrast agents: A single-center retrospective analysis over 7 years.
    Mankouri F; Gauthier A; Srisuwatchari W; Moutou A; Borushko A; Popa L; Ehrhardt Y; Demoly P; Chiriac AM
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1746-1749.e2. PubMed ID: 33248281
    [No Abstract]   [Full Text] [Related]  

  • 11. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
    Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
    PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of magnetic resonance contrast media.
    Runge VM
    Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction.
    Martin DR
    Top Magn Reson Imaging; 2016 Dec; 25(6):255. PubMed ID: 27849655
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
    Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
    [No Abstract]   [Full Text] [Related]  

  • 15. Gadolinium-Based Contrast Agents: Associated Adverse Reactions.
    Ramalho M; Ramalho J
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):755-764. PubMed ID: 28964465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
    Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
    Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast Reaction Readiness for Your Department or Facility.
    Wang CL; Soloff EV
    Radiol Clin North Am; 2020 Sep; 58(5):841-850. PubMed ID: 32792118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute allergic reaction upon first exposure to gadolinium-DTPA: a case report.
    Rahman SL; Harbinson MT; Mohiaddin R; Pennell DJ
    J Cardiovasc Magn Reson; 2005; 7(5):849-51. PubMed ID: 16353448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.